1,000 jobs to go in Mediceo Paltac restructuring
This article was originally published in Scrip
Japan's largest pharmaceutical wholesaler, Mediceo Paltac Holdings, is planning to cut 1,000 jobs in its group firms through an early retirement programme, in a move indicative of the problems facing the sector.
You may also be interested in...
Product review report reveals multiple delays and missteps on route to market, holding valuable lessons for other gene therapy developers but also evidencing an ultimately welcoming environment.
Join us for a quick audio roundup of major developments in the international biopharma industry over the past week, as covered by Scrip's global team.
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.